A $625 Million Deal A Long Time In The Making After several months of potential bidders taking a look at the assets and operations of Harborside Healthcare Corporation, and with investment banker UBS Investment Bank narrowing the field down to the final four or...
Rob Mains, Manging Director and Equity Analyst, Ryan Beck & Co. Why are health care REIT stocks performing so well in 2006? Should more of them diversify into the medical office building market? Do the differences in dividend yield among the health care REITs...
Email Editor Eisai Co. Ltd. (T: 4523), through its American subsidiary, is acquiring four oncology-related products from Ligand for $205.0 million, or 3.87x revenue. The products include ONTAK, Targretin capsules, Targretin gel 1% and Panretin gel 1%. Eisai’s goals in...
Email Editor Based on preliminary figures, a total of 237 mergers and acquisitions were announced in the health care industry during the third quarter of 2006. The nine sectors of the health care services segment accounted for 136 deals, or 57% of the quarter’s total...
Three Family-Owned European Drug Firms Sell In One Week Email Editor Dealmaking in the Pharmaceuticals sector, as well as reporting on it, has often focused on two extremes: the merger of mega-pharma conglomerates at one end and the consolidation of generic pharma...
The Clock Is Ticking, But Ventas Is Not Distracted The appraisals for the Kindred Healthcare (NYSE: KND) rent-reset with Ventas (NYSE: VTR) are due to both parties on October 7, which just happens to be a Saturday, so they may have to wait until Monday. But that is a...